nivolumab
Drug Details
- Generic Name
- nivolumab
- Brand Names
- OPDIVO
- Application Number
- BLA125554
- Sponsor
- Catalent Indiana, LLC
- NDC Codes
- 6
- Dosage Forms
- INJECTION, SOLUTION, INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- NIVOLUMAB
Indications and Usage
1 INDICATIONS AND USAGE OPDUALAG™ is indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. OPDUALAG is a combination of nivolumab, a programmed death receptor-1 (PD-1) blocking antibody, and relatlimab, a lymphocyte activation gene-3 (LAG-3) blocking antibody, indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. (1)